Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > iPSC-derived Cell Therapy: Where Are We Now, and What’s Next?
  1. iPSC-derived Cell Therapy: Where Are We Now, and What’s Next?

    1. March 31st
    2. Online
    3. ACROBiosystems
    Click the button to enter our raffle.
  2. Watch the Webinar on Demand!




    Speaker and Agenda

    Jordon Wang

    Ruiyuan Zheng, PhD

    Marketing Product Manager, ACROBiosystems

    Ruiyuan Zheng is a Marketing Product Manager at ACROBiosystems, specializing in cell and gene therapy (CGT). With a PhD in chromatin and cell biology from the University of Cologne and postdoctoral research in organoid-based disease models at Heidelberg University, she brings deep expertise in iPSC technology and its applications in regenerative medicine. Now, she focuses on customer engagement and marketing analysis, leveraging her scientific background to drive innovation and strategy in the CGT field.

    Abstract: Stem cells hold immense promises for regenerative medicine and cell therapies, offering the potential to revolutionize the treatment of a wide range of diseases. However, realizing this potential requires robust and scalable methods for stem cell expansion and differentiation under stringent GMP conditions. This presentation delves into the landscape of stem cell technologies, highlighting the capabilities of iPSCs and HSCs for cell therapy applications. We showcase our expertise in GMP-compliant stem cell manufacturing, encompassing the expansion and differentiation of iPSCs into various cell types, including immune cells, neural cells, and organoids. We also present our GMP-compliant IPSC and HSC products, paving the way for advanced cell therapies that address unmet medical needs.

    Related Reading:

    Universal CAR-NK Cell Therapy: The Promising Future of Targeted Cancer Immunotherapy icon

    Utilizing GMP-Grade Laminin for Scalable Manufacturing of iPSC-Derived Cell Therapies icon

    A Promising Approach for Improving CAR Cell Activation, Expansion, Enrichment, and In Vitro Analysis icon

    Organisers

    ACRO

New & Hot Products


This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message